Citigroup
OPK icon

Citigroup’s Opko Health OPK Stock Holding History

Citigroup’s Portfolio OPK Stock Details OPK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-70,500
Closed -$278K – 7081
2020
Q4 		$278K Buy
70,500
+31,400
+80% +$131K ﹤0.01% 4731
2020
Q3 		$144K Buy
39,100
+10,300
+36% +$43.5K ﹤0.01% 4845
2020
Q2 		$98K Hold
28,800
– – ﹤0.01% 5595
2020
Q1 		$39K Sell
28,800
-5,000
-15% -$7.83K ﹤0.01% 6201
2019
Q4 		$50K Sell
33,800
-7,300
-18% -$12.2K ﹤0.01% 6308
2019
Q3 		$86K Sell
41,100
-1,800
-4% -$3.68K ﹤0.01% 5782
2019
Q2 		$105K Buy
42,900
+40,900
+2,045% +$89.2K ﹤0.01% 5828
2019
Q1 		$5K Sell
2,000
-58,500
-97% -$177K ﹤0.01% 7422
2018
Q4 		$182K Sell
60,500
-6,300
-9% -$21.4K ﹤0.01% 5116
2018
Q3 		$231K Sell
66,800
-78,300
-54% -$416K ﹤0.01% 5108
2018
Q2 		$682K Buy
145,100
+58,900
+68% +$223K ﹤0.01% 3758
2018
Q1 		$273K Buy
86,200
+17,400
+25% +$70.1K ﹤0.01% 4619
2017
Q4 		$337K Sell
68,800
-14,600
-18% -$84.7K ﹤0.01% 4527
2017
Q3 		$572K Buy
83,400
+24,700
+42% +$156K ﹤0.01% 3978
2017
Q2 		$386K Buy
58,700
+14,400
+33% +$101K ﹤0.01% 4216
2017
Q1 		$354K Sell
44,300
-16,100
-27% -$136K ﹤0.01% 4155
2016
Q4 		$562K Buy
60,400
+19,600
+48% +$203K ﹤0.01% 4255
2016
Q3 		$432K Sell
40,800
-38,700
-49% -$385K ﹤0.01% 4027
2016
Q2 		$742K Buy
79,500
+5,800
+8% +$58.9K ﹤0.01% 3237
2016
Q1 		$766K Sell
73,700
-221,100
-75% -$2.02M ﹤0.01% 3652
2015
Q4 		$2.96M Sell
294,800
-1,000
-0.3% -$10K ﹤0.01% 2171
2015
Q3 		$2.49M Buy
295,800
+5,000
+2% +$66.2K ﹤0.01% 2260
2015
Q2 		$4.68M Buy
290,800
+10,800
+4% +$168K ﹤0.01% 1787
2015
Q1 		$3.97M Buy
280,000
+100,000
+56% +$1.3M ﹤0.01% 1925
2014
Q4 		$1.8M Buy
180,000
+100,000
+125% +$856K ﹤0.01% 2559
2014
Q3 		$681K Buy
+80,000
New +$703K ﹤0.01% 3301

Other funds holding OPK

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WCM
Whitefort Capital Management New York $339M AUM 52.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citigroup's OPK Position: Q1 2026 in Review

Citigroup increased its Opko Health (OPK) stake by 104% in Q1 2026, buying an estimated $21.1K and bringing the position to 33,676 shares worth $38.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4626.

Citigroup first reported a position in OPK in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.41M in Q4 2018. 235 funds tracked by Wall St. Rank hold OPK as of Q1 2026.

  • Citigroup held 33,676 shares of Opko Health worth $38.4K as of Q1 2026.
  • Citigroup bought 17,134 Opko Health shares in Q1 2026, an estimated $21.1K.
  • Opko Health made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #4626 holding.
  • Citigroup first reported a position in Opko Health in Q2 2013 and has held it in 52 quarters since.
  • Citigroup's Opko Health position peaked at $6.41M in Q4 2018.
  • 235 funds tracked by Wall St. Rank held Opko Health as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.